{"id":998554,"date":"2026-08-27T09:19:06","date_gmt":"2026-08-27T13:19:06","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-ceo-sabrina-martucci-johnson-participates-in-the-virtual-investor-why-now-on-demand-series\/"},"modified":"2026-08-27T09:19:06","modified_gmt":"2026-08-27T13:19:06","slug":"dare-bioscience-ceo-sabrina-martucci-johnson-participates-in-the-virtual-investor-why-now-on-demand-series","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-ceo-sabrina-martucci-johnson-participates-in-the-virtual-investor-why-now-on-demand-series\/","title":{"rendered":"Dar\u00e9 Bioscience CEO, Sabrina Martucci Johnson, Participates in the Virtual Investor \u201cWhy Now\u201d On-Demand Series"},"content":{"rendered":"
\n

\n Video webcast now available\u00a0<\/em>
\n
\n here<\/em>
\n <\/a>\n <\/p>\n

SAN DIEGO, Aug. 27, 2026 (GLOBE NEWSWIRE) — Dar\u00e9 Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women’s health between promising science and real-world solutions, today announced that it participated in the Virtual Investor \u201cWhy Now\u201d on-demand series<\/a>.<\/p>\n

For the webcast, Sabrina Martucci Johnson, President and Chief Executive Officer<\/a> of Dar\u00e9 Bioscience, presented the Company’s investment thesis, highlighting its mission to advance innovative solutions that address significant unmet needs in women’s health through a differentiated, science based and capital-efficient business model. Ms. Johnson underscored Dar\u00e9 Bioscience’s first direct product launch, its diversified pipeline, and its strategic collaboration-driven development approach.<\/p>\n

The video webcast is now accessible for on-demand viewing here<\/a>.<\/p>\n

\n
\n ABOUT DAR\u00c9 BIOSCIENCE, INC.<\/u>
\n <\/strong>\n <\/p>\n

Dar\u00e9 Bioscience (NASDAQ: DARE) is a purpose-driven health biotech company solely focused on closing the gap in women\u2019s health between promising science and real-world solutions. Every innovation Dar\u00e9 Bioscience advances is based in advanced science and backed by rigorous, peer-reviewed research. From contraception to menopause, sexual health to fertility, vaginal health to infectious disease, Dar\u00e9 Bioscience is working to close critical gaps in care using science that serves her needs. For decades, women have been told to \u201cwait it out\u201d or \u201clive with it,\u201d while innovations that could improve their quality of life languish in the regulatory or funding pipeline. With growing awareness around menopause, sexual health, and vaginal health, the conversation is shifting. However, access to proven solutions is lagging. Dar\u00e9 Bioscience is working to change that. Learn more at darebioscience.com<\/a>.<\/p>\n

\n Contact:<\/strong>
\n
\n Dar\u00e9 Bioscience Investor Relations<\/strong>
\n
innovations@darebioscience.com
Source: Dar\u00e9 Bioscience, Inc.<\/em><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Video webcast now available\u00a0 here SAN DIEGO, Aug. 27, 2026 (GLOBE NEWSWIRE) — Dar\u00e9 Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women’s health between promising science and real-world solutions, today announced that it participated in the Virtual Investor \u201cWhy Now\u201d on-demand series. For the webcast, Sabrina Martucci Johnson, President and Chief Executive Officer of Dar\u00e9 Bioscience, presented the Company’s investment thesis, highlighting its mission to advance innovative solutions that address significant unmet needs in women’s health through a differentiated, science based and capital-efficient business model. Ms. Johnson underscored Dar\u00e9 Bioscience’s first direct product launch, its diversified pipeline, and its strategic collaboration-driven development approach. The video webcast is now accessible for on-demand … <\/p>\n

Continue reading “Dar\u00e9 Bioscience CEO, Sabrina Martucci Johnson, Participates in the Virtual Investor \u201cWhy Now\u201d On-Demand Series”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-998554","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nDar\u00e9 Bioscience CEO, Sabrina Martucci Johnson, Participates in the Virtual Investor \u201cWhy Now\u201d On-Demand Series - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-ceo-sabrina-martucci-johnson-participates-in-the-virtual-investor-why-now-on-demand-series\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dar\u00e9 Bioscience CEO, Sabrina Martucci Johnson, Participates in the Virtual Investor \u201cWhy Now\u201d On-Demand Series - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Video webcast now available\u00a0 here SAN DIEGO, Aug. 27, 2026 (GLOBE NEWSWIRE) — Dar\u00e9 Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women’s health between promising science and real-world solutions, today announced that it participated in the Virtual Investor \u201cWhy Now\u201d on-demand series. For the webcast, Sabrina Martucci Johnson, President and Chief Executive Officer of Dar\u00e9 Bioscience, presented the Company’s investment thesis, highlighting its mission to advance innovative solutions that address significant unmet needs in women’s health through a differentiated, science based and capital-efficient business model. Ms. Johnson underscored Dar\u00e9 Bioscience’s first direct product launch, its diversified pipeline, and its strategic collaboration-driven development approach. The video webcast is now accessible for on-demand … Continue reading "Dar\u00e9 Bioscience CEO, Sabrina Martucci Johnson, Participates in the Virtual Investor \u201cWhy Now\u201d On-Demand Series"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-ceo-sabrina-martucci-johnson-participates-in-the-virtual-investor-why-now-on-demand-series\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-27T13:19:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNjg0OCM3ODA1MzU1IzIwMDgzNjQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-ceo-sabrina-martucci-johnson-participates-in-the-virtual-investor-why-now-on-demand-series\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-ceo-sabrina-martucci-johnson-participates-in-the-virtual-investor-why-now-on-demand-series\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Dar\u00e9 Bioscience CEO, Sabrina Martucci Johnson, Participates in the Virtual Investor \u201cWhy Now\u201d On-Demand Series\",\"datePublished\":\"2026-08-27T13:19:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-ceo-sabrina-martucci-johnson-participates-in-the-virtual-investor-why-now-on-demand-series\\\/\"},\"wordCount\":285,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-ceo-sabrina-martucci-johnson-participates-in-the-virtual-investor-why-now-on-demand-series\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxNjg0OCM3ODA1MzU1IzIwMDgzNjQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-ceo-sabrina-martucci-johnson-participates-in-the-virtual-investor-why-now-on-demand-series\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-ceo-sabrina-martucci-johnson-participates-in-the-virtual-investor-why-now-on-demand-series\\\/\",\"name\":\"Dar\u00e9 Bioscience CEO, Sabrina Martucci Johnson, Participates in the Virtual Investor \u201cWhy Now\u201d On-Demand Series - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-ceo-sabrina-martucci-johnson-participates-in-the-virtual-investor-why-now-on-demand-series\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-ceo-sabrina-martucci-johnson-participates-in-the-virtual-investor-why-now-on-demand-series\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxNjg0OCM3ODA1MzU1IzIwMDgzNjQ=\",\"datePublished\":\"2026-08-27T13:19:06+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-ceo-sabrina-martucci-johnson-participates-in-the-virtual-investor-why-now-on-demand-series\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-ceo-sabrina-martucci-johnson-participates-in-the-virtual-investor-why-now-on-demand-series\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-ceo-sabrina-martucci-johnson-participates-in-the-virtual-investor-why-now-on-demand-series\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxNjg0OCM3ODA1MzU1IzIwMDgzNjQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxNjg0OCM3ODA1MzU1IzIwMDgzNjQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-ceo-sabrina-martucci-johnson-participates-in-the-virtual-investor-why-now-on-demand-series\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dar\u00e9 Bioscience CEO, Sabrina Martucci Johnson, Participates in the Virtual Investor \u201cWhy Now\u201d On-Demand Series\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dar\u00e9 Bioscience CEO, Sabrina Martucci Johnson, Participates in the Virtual Investor \u201cWhy Now\u201d On-Demand Series - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-ceo-sabrina-martucci-johnson-participates-in-the-virtual-investor-why-now-on-demand-series\/","og_locale":"en_US","og_type":"article","og_title":"Dar\u00e9 Bioscience CEO, Sabrina Martucci Johnson, Participates in the Virtual Investor \u201cWhy Now\u201d On-Demand Series - Market Newsdesk","og_description":"Video webcast now available\u00a0 here SAN DIEGO, Aug. 27, 2026 (GLOBE NEWSWIRE) — Dar\u00e9 Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women’s health between promising science and real-world solutions, today announced that it participated in the Virtual Investor \u201cWhy Now\u201d on-demand series. For the webcast, Sabrina Martucci Johnson, President and Chief Executive Officer of Dar\u00e9 Bioscience, presented the Company’s investment thesis, highlighting its mission to advance innovative solutions that address significant unmet needs in women’s health through a differentiated, science based and capital-efficient business model. Ms. Johnson underscored Dar\u00e9 Bioscience’s first direct product launch, its diversified pipeline, and its strategic collaboration-driven development approach. The video webcast is now accessible for on-demand … Continue reading \"Dar\u00e9 Bioscience CEO, Sabrina Martucci Johnson, Participates in the Virtual Investor \u201cWhy Now\u201d On-Demand Series\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-ceo-sabrina-martucci-johnson-participates-in-the-virtual-investor-why-now-on-demand-series\/","og_site_name":"Market Newsdesk","article_published_time":"2026-08-27T13:19:06+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNjg0OCM3ODA1MzU1IzIwMDgzNjQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-ceo-sabrina-martucci-johnson-participates-in-the-virtual-investor-why-now-on-demand-series\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-ceo-sabrina-martucci-johnson-participates-in-the-virtual-investor-why-now-on-demand-series\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Dar\u00e9 Bioscience CEO, Sabrina Martucci Johnson, Participates in the Virtual Investor \u201cWhy Now\u201d On-Demand Series","datePublished":"2026-08-27T13:19:06+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-ceo-sabrina-martucci-johnson-participates-in-the-virtual-investor-why-now-on-demand-series\/"},"wordCount":285,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-ceo-sabrina-martucci-johnson-participates-in-the-virtual-investor-why-now-on-demand-series\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNjg0OCM3ODA1MzU1IzIwMDgzNjQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-ceo-sabrina-martucci-johnson-participates-in-the-virtual-investor-why-now-on-demand-series\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-ceo-sabrina-martucci-johnson-participates-in-the-virtual-investor-why-now-on-demand-series\/","name":"Dar\u00e9 Bioscience CEO, Sabrina Martucci Johnson, Participates in the Virtual Investor \u201cWhy Now\u201d On-Demand Series - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-ceo-sabrina-martucci-johnson-participates-in-the-virtual-investor-why-now-on-demand-series\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-ceo-sabrina-martucci-johnson-participates-in-the-virtual-investor-why-now-on-demand-series\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNjg0OCM3ODA1MzU1IzIwMDgzNjQ=","datePublished":"2026-08-27T13:19:06+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-ceo-sabrina-martucci-johnson-participates-in-the-virtual-investor-why-now-on-demand-series\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-ceo-sabrina-martucci-johnson-participates-in-the-virtual-investor-why-now-on-demand-series\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-ceo-sabrina-martucci-johnson-participates-in-the-virtual-investor-why-now-on-demand-series\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNjg0OCM3ODA1MzU1IzIwMDgzNjQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNjg0OCM3ODA1MzU1IzIwMDgzNjQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-ceo-sabrina-martucci-johnson-participates-in-the-virtual-investor-why-now-on-demand-series\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Dar\u00e9 Bioscience CEO, Sabrina Martucci Johnson, Participates in the Virtual Investor \u201cWhy Now\u201d On-Demand Series"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/998554","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=998554"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/998554\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=998554"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=998554"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=998554"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}